The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1. (Q39402118)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302610%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302610%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302610%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Juan Segura-Aguilar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302610%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Marco T. Nunez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302610%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Pabla Aguirre

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302610%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Pamela Urrutia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302610%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Victoria Tapia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302610%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Monica Villa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302610%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

1 reference

1 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302610%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302610%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302610%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302610%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

795-803

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302610%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10534-012-9525-y

22 January 2020

exact match

0 references

cites work

Iron homeostasis in neuronal cells: a role for IREG1

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Upregulation of gamma-glutamate-cysteine ligase as part of the long-term adaptation process to iron accumulation in neuronal SH-SY5Y cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Brain mitochondrial complex I inactivation by oxidative modification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Stages in the development of Parkinson's disease-related pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Redox-dependent modulation of aconitase activity in intact mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Mitochondria deficient in complex I activity are depolarized by hydrogen peroxide in nerve terminals: relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Dopamine but not 3,4-dihydroxy phenylacetic acid (DOPAC) inhibits brain respiratory chain activity by autoxidation and mitochondria catalyzed oxidation to quinone products: implications in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Hepcidin inhibits apical iron uptake in intestinal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Effect of mitochondrial complex I inhibition on Fe-S cluster protein activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Iron supply determines apical/basolateral membrane distribution of intestinal iron transporters DMT1 and ferroportin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Differential effects of insulin on peripheral diabetes-related changes in mitochondrial bioenergetics: involvement of advanced glycosylated end products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Complex I: inhibitors, inhibition and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Mitochondrial complex I deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y

Dopamine-derived dopaminochrome promotes H(2)O(2) release at mitochondrial complex I: stimulation by rotenone, control by Ca(2+), and relevance to Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9525-Y